Towards Definitive Management of Allergic Rhinitis Best use of new and established therapies

Towards Definitive Management of Allergic Rhinitis
Best use of new and established therapies

Allergic rhinitis (AR) is an inflammatory disease of the nasal mucosa impacting almost 25% of Canadians and up to 38.5% of South Africans. The standard of care for AR includes a treatment plan that takes into account patient preferences, the severity of the disease, and most essentially involves a shared decision-making process between patient and provider. This is a shortened version of the original open access article.

Modern Medicine – Issue 3 2021